Comment on 'Randomised phase 2 study of pembrolizumab plus CC-486 versus pembrolizumab plus placebo in patients with previously treated advanced non-small cell lung cancer'-No support for de-escalation of immunotherapy

被引：1

作者：

Georgiou, Alexandros ^{[1
]}

Minchom, Anna ^{[1
]}

O'Brien, Mary ^{[1
]}

机构：

[1] Royal Marsden Hosp Fdn Trust, London, England

来源：

EUROPEAN JOURNAL OF CANCER | 2019年 / 115卷

关键词：

DOCETAXEL; NIVOLUMAB; ATEZOLIZUMAB;

D O I：

10.1016/j.ejca.2019.04.011

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：24 / 26

页数：3

共 50 条

[31] Ramucirumab plus atezolizumab in patients with stage IV non-small cell lung cancer previously treated with immune checkpoint inhibitors [J].

Herzog, Brett H. ;

Waqar, Saiama N. ;

Devarakonda, Siddhartha ;

Ward, Jeffrey P. ;

Gao, Feng ;

Govindan, Ramaswamy ;

Morgensztern, Daniel .

LUNG CANCER, 2022, 173 :101-106

[32] Efficacy and safety of sintilimab plus docetaxel in patients with previously treated advanced non-small cell lung cancer: a prospective, single-arm, phase II study in China [J].

Han, Xiao ;

Guo, Jun ;

Tang, Xiaoyong ;

Zhu, Hui ;

Zhu, Dongyuan ;

Zhang, Xiqin ;

Meng, Xiangjiao ;

Hua, Ying ;

Wang, Zhongtang ;

Zhang, Yan ;

Huang, Wei ;

Wang, Linlin ;

Yuan, Shuanghu ;

Zhang, Pingliang ;

Gong, Heyi ;

Sun, Yulan ;

Zhang, Yingjie ;

Liu, Zengjun ;

Wang, Zhehai .

JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (04) :1443-1451

[33] Nivolumab Versus Docetaxel in Patients With Previously Treated Advanced Non-Small Cell Lung Cancer and Liver Metastases [J].

Crino, L. ;

Horn, L. ;

Felip, E. ;

Frontera, O. Aren ;

Burgio, M. ;

Waterhouse, D. ;

Blumenschein, G. ;

Barlesi, F. ;

Garassino, M. ;

Holgado, E. ;

Antonia, S. ;

Spigel, D. ;

Gainor, J. ;

Gettinger, S. ;

Geese, W. ;

Li, A. ;

Healey, D. ;

Ready, N. .

JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) :S2302-S2302

[34] Concomitant Proton Pump Inhibitor Use With Pembrolizumab Monotherapy vs Immune Checkpoint Inhibitor Plus Chemotherapy in Patients With Non-Small Cell Lung Cancer [J].

Kawachi, Hayato ;

Yamada, Tadaaki ;

Tamiya, Motohiro ;

Negi, Yoshiki ;

Goto, Yasuhiro ;

Nakao, Akira ;

Shiotsu, Shinsuke ;

Tanimura, Keiko ;

Takeda, Takayuki ;

Okada, Asuka ;

Harada, Taishi ;

Date, Koji ;

Chihara, Yusuke ;

Hasegawa, Isao ;

Tamiya, Nobuyo ;

Ishida, Masaki ;

Katayama, Yuki ;

Morimoto, Kenji ;

Iwasaku, Masahiro ;

Tokuda, Shinsaku ;

Kijima, Takashi ;

Takayama, Koichi .

JAMA NETWORK OPEN, 2023, 6 (07) :e2322915

[35] A phase 2 trial of chemotherapy plus pembrolizumab in patients with advanced non-small cell lung cancer previously treated with a PD-1 or PD-L1 inhibitor: Big Ten Cancer Research Consortium BTCRC-LUN15-029 [J].

Salous, Tareq ;

Shukla, Nikhil A. A. ;

Althouse, Sandra K. K. ;

Perkins, Susan M. M. ;

Furqan, Muhammad ;

Leal, Ticiana ;

Traynor, Anne M. M. ;

Feldman, Lawrence E. E. ;

Hanna, Nasser H. H. ;

Durm, Greg A. A. .

CANCER, 2023, 129 (02) :264-271

[36] Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial [J].

Herbst, Roy S. ;

Baas, Paul ;

Kim, Dong-Wan ;

Felip, Enriqueta ;

Perez-Gracia, Jose L. ;

Han, Ji-Youn ;

Molina, Julian ;

Kim, Joo-Hang ;

Arvis, Catherine Dubos ;

Ahn, Myung-Ju ;

Majem, Margarita ;

Fidler, Mary J. ;

de Castro, Gilberto, Jr. ;

Garrido, Marcelo ;

Lubiniecki, Gregory M. ;

Shentu, Yue ;

Im, Ellie ;

Dolled-Filhart, Marisa ;

Garon, Edward B. .

LANCET, 2016, 387 (10027) :1540-1550

[37] Phase II study of S-1 plus bevacizumab combination therapy for patients previously treated for non-squamous non-small cell lung cancer [J].

Nishijima-Futami, Yu ;

Minami, Seigo ;

Futami, Shinji ;

Koba, Taro ;

Higashiguchi, Masayoshi ;

Tamiya, Motohiro ;

Suzuki, Hidekazu ;

Hirashima, Tomonori ;

Komuta, Kiyoshi ;

Kijima, Takashi .

CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) :1215-1220

[38] A phase I/II study of pemetrexed with sirolimus in advanced, previously treated non-small cell lung cancer [J].

Komiya, Takefumi ;

Memmott, Regan M. ;

Blumenthal, Gideon M. ;

Bernstein, Wendy ;

Ballas, Marc S. ;

De Chowdhury, Roopa ;

Chun, Guinevere ;

Peer, Cody J. ;

Figg, William D. ;

Liewehr, David J. ;

Steinberg, Seth M. ;

Giaccone, Giuseppe ;

Szabo, Eva ;

Kawabata, Shigeru ;

Tsurutani, Junji ;

Rajan, Arun ;

Dennis, Phillip A. .

TRANSLATIONAL LUNG CANCER RESEARCH, 2019, 8 (03) :247-+

[39] A randomized phase III study of docetaxel alone versus docetaxel plus S-1 in patients with previously treated non-small cell lung cancer: JMTO LC09-01 [J].

Atagi, Shinji ;

Daimon, Takashi ;

Okishio, Kyoichi ;

Komuta, Kiyoshi ;

Okano, Yoshio ;

Minato, Koichi ;

Kim, Young Hak ;

Usui, Ryo ;

Tabata, Chiharu ;

Tamura, Atsuhisa ;

Kawahara, Masaaki .

THORACIC CANCER, 2023, 14 (29) :2941-2949

[40] Phase II study of continuous daily sunitinib dosing in patients with previously treated advanced non-small cell lung cancer [J].

Novello, S. ;

Scagliotti, G. V. ;

Rosell, R. ;

Socinski, M. A. ;

Brahmer, J. ;

Atkins, J. ;

Pallares, C. ;

Burgess, R. ;

Tye, L. ;

Selaru, P. ;

Wang, E. ;

Chao, R. ;

Govindan, R. .

BRITISH JOURNAL OF CANCER, 2009, 101 (09) :1543-1548

← 1 2 3 4 5 →